CD40 and breast cancer: After transfer, these Tregs lose their FoxP3 expression and migrate into B-cell follicles, in which they differentiate into TFH cells on CD40/CD40L-dependent interaction with B cells and consistent with the detection of TFH in breast cancer- and NSCLC-associated TLS (38–40).